Edgewise Therapeutics (EWTX) News Today $31.95 +0.44 (+1.40%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2024 Earnings Forecast for EWTX Issued By Leerink PartnrsNovember 17, 2024 | americanbankingnews.comWhat is Leerink Partnrs' Forecast for EWTX FY2024 Earnings?Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) - Research analysts at Leerink Partnrs increased their FY2024 earnings estimates for shares of Edgewise Therapeutics in a report released on Tuesday, November 12th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will poNovember 15, 2024 | marketbeat.comOptimistic Outlook for Edgewise Therapeutics with Focus on Sevasemten Data MilestonesNovember 14, 2024 | markets.businessinsider.comWedbush Raises Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $45.00Wedbush raised their price target on shares of Edgewise Therapeutics from $44.00 to $45.00 and gave the company an "outperform" rating in a report on Friday.November 8, 2024 | marketbeat.comabrdn plc Acquires New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)abrdn plc acquired a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 256,645 shares of the company's stock, valued at approximately $6,850,000.November 3, 2024 | marketbeat.comNovo Holdings A S Has $148.13 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Novo Holdings A S reduced its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 12.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,549,900 shares of the company's stock after selling 794,530 shaOctober 27, 2024 | marketbeat.comMoody Aldrich Partners LLC Acquires New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Moody Aldrich Partners LLC bought a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 151,157 shares of the company's stock,October 24, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week High - Should You Buy?Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High - Still a Buy?October 15, 2024 | marketbeat.comSG Americas Securities LLC Sells 34,544 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)SG Americas Securities LLC decreased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 53.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,629 shares of the compOctober 13, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 4.5% After Analyst UpgradeEdgewise Therapeutics (NASDAQ:EWTX) Trading 4.5% Higher After Analyst UpgradeOctober 11, 2024 | marketbeat.comPiper Sandler Boosts Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $51.00Piper Sandler lifted their target price on Edgewise Therapeutics from $48.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday.October 11, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and AnaptysBio (ANAB)October 9, 2024 | markets.businessinsider.comEdgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High - Here's WhyEdgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week High - Here's WhyOctober 9, 2024 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX), AnaptysBio (ANAB) and Edgewise Therapeutics (EWTX)October 8, 2024 | markets.businessinsider.comDimensional Fund Advisors LP Increases Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Dimensional Fund Advisors LP raised its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 56.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 467,507 shares oOctober 8, 2024 | marketbeat.comEdgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy NowOctober 7, 2024 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - Here's What HappenedEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - What's Next?October 7, 2024 | marketbeat.comSquarepoint Ops LLC Purchases 27,687 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Squarepoint Ops LLC boosted its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 111.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,541 shares of the company's stock after purchasing aOctober 7, 2024 | marketbeat.comMillennium Management LLC Purchases 613,251 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Millennium Management LLC raised its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 115.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,145,506 shares of the company's stock after pOctober 5, 2024 | marketbeat.comMarshall Wace LLP Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Marshall Wace LLP grew its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 661.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 415,720 shares of the company's stock after buying an additiOctober 1, 2024 | marketbeat.com6,344,430 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Novo Holdings A SNovo Holdings A S bought a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought 6,344,430 shares of the company's stock, valued at approximately $114,263,000. Edgewise Therapeutics comprisesSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Buys 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Frazier Life Sciences Management L.P. increased its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 12.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,731,067 shares of the company's stock after purchasing an additional 4September 29, 2024 | marketbeat.comMarketBeat Week in Review – 9/23 - 9/27 (EWTX)Stocks had a mostly bullish week as stimulus efforts in the U.S. and China enhanced risk-on sentiment, but next week's jobs report could spark a larger rallySeptember 28, 2024 | marketbeat.comEdgewise Therapeutics (EWTX) Gets a Buy from Truist FinancialSeptember 26, 2024 | markets.businessinsider.comAnalyst Think There's Still Time to Get in on Edgewise, Up 332%September 25, 2024 | msn.comAnalysts Think There's Still Time to Get in on Edgewise, Up 332%Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?September 25, 2024 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CMO Sells $202,612.98 in StockSeptember 25, 2024 | insidertrades.comEWTX Oct 2024 20.000 callSeptember 25, 2024 | ca.finance.yahoo.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 6.9%Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 6.9%September 23, 2024 | marketbeat.com46,234 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Federated Hermes Inc.Federated Hermes Inc. purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 46,234 shares of the company'September 23, 2024 | marketbeat.comBausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?September 22, 2024 | benzinga.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by American Century Companies Inc.American Century Companies Inc. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 53.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 860,067 shares of the company's stock after buying an additional 300,733 shSeptember 21, 2024 | marketbeat.comBuy Rating Affirmed on Edgewise Therapeutics’ EDG-7500 for HCM Treatment Due to Promising Efficacy and Safety ProfileSeptember 20, 2024 | markets.businessinsider.comEWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot?September 20, 2024 | markets.businessinsider.comEdgewise Therapeutics Shares Rise on Positive Results for Heart-Disease TreatmentSeptember 19, 2024 | marketwatch.comEdgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade)September 19, 2024 | seekingalpha.comEdgewise Therapeutics Soars 50%: Key Reasons Behind the SurgeEdgewise Therapeutics is rocketing higher on positive results for its HCM combating treatment and short-covering. Expect volatility in the weeks ahead.September 19, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) PT Raised to $33.00 at Truist FinancialTruist Financial upped their price objective on Edgewise Therapeutics from $25.00 to $33.00 and gave the company a "buy" rating in a research report on Thursday.September 19, 2024 | marketbeat.comWhy Edgewise Therapeutics Stock Is Up 50% on ThursdaySeptember 19, 2024 | fool.comEdgewise Therapeutics Sees Unusually Large Options Volume (NASDAQ:EWTX)Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the recipient of unusually large options trading on Thursday. Traders bought 3,952 put options on the stock. This is an increase of 400% compared to the average volume of 790 put options.September 19, 2024 | marketbeat.comEdgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart TreatmentSeptember 19, 2024 | benzinga.comEdgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares DipSeptember 19, 2024 | investors.comEdgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)September 19, 2024 | businesswire.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up to $18.08Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up to $18.08September 18, 2024 | marketbeat.comEdgewise jumps ahead of 'key stock-moving event'September 17, 2024 | seekingalpha.comEdgewise Therapeutics (NASDAQ:EWTX) Sees Strong Trading VolumeEdgewise Therapeutics (NASDAQ:EWTX) Sees Unusually-High Trading VolumeSeptember 17, 2024 | marketbeat.comEdgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern TimeSeptember 17, 2024 | businesswire.comEdgewise Therapeutics (NASDAQ:EWTX) Earns Outperform Rating from Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a $32.00 target price on shares of Edgewise Therapeutics in a research report on Tuesday.September 17, 2024 | marketbeat.com475,691 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Sofinnova Investments Inc.Sofinnova Investments Inc. purchased a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 475,691 shares of the company's stock, valued at approxiSeptember 17, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.4%Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.4%September 16, 2024 | marketbeat.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼0.660.46▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼63▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kura Oncology News Today AnaptysBio News Today Arcturus Therapeutics News Today MaxCyte News Today Solid Biosciences News Today Heron Therapeutics News Today Gossamer Bio News Today Vaxcyte News Today Catalent News Today Sarepta Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
